Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: A Contemporary Series From the Bladder Cancer Research Consortium

Journal of Urology

Volumn 176, Issue 6, 2006, Pages 2414-2422

  Shariat, Shahrokh F ^a   Karakiewicz, Pierre I ^c   Palapattu, Ganesh S ^d   Lotan, Yair ^a   Rogers, Craig G ^d   Amiel, Gilad E ^b   Vazina, Amnon ^b   Gupta, Amit ^a   Bastian, Patrick J ^d   Sagalowsky, Arthur I ^a   Schoenberg, Mark P ^d   Lerner, Seth P ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

bladder; bladder neoplasms; carcinoma; cystectomy; mortality; transitional cell

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RESEARCH; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; CYSTECTOMY; DATA ANALYSIS; DATA BASE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; RECURRENCE RISK; STATISTICAL SIGNIFICANCE; TRANSITIONAL CELL CARCINOMA; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; CYSTECTOMY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; REGRESSION ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 33751057732     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.08.004     Document Type: Article

References (19)

1. Stein J.P., Lieskovsky G., Cote R., Groshen S., Feng A.C., Boyd S., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666
2. Madersbacher S., Hochreiter W., Burkhard F., Thalmann G.N., Danuser H., Markwalder R., et al. Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 21 (2003) 690
3. Dalbagni G., Genega E., Hashibe M., Zhang Z.F., Russo P., Herr H., et al. Cystectomy for bladder cancer: a contemporary series. J Urol 165 (2001) 1111
4. Hautmann R.E., and Simon J. Ileal neobladder and local recurrence of bladder cancer: patterns of failure and impact on function in men. J Urol 162 (1999) 1963
5. Vazina A., Dugi D., Shariat S.F., Evans J., Link R., and Lerner S.P. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 171 (2004) 1830
6. Leissner J., Ghoneim M.A., Abol-Enein H., Thuroff J.W., Franzaring L., Fisch M., et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 171 (2004) 139
7. Poulsen A.L., Horn T., and Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 160 (1998) 2015
8. Gschwend J.E., Fair W.R., and Vieweg J. Radical cystectomy for invasive bladder cancer: contemporary results and remaining controversies. Eur Urol 38 (2000) 121
9. Lotan Y., Gupta A., Shariat S.F., Palapattu G.S., Vazina A., Karakiewicz P.I., et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23 (2005) 6533
10. Schoenberg M.P., Walsh P.C., Breazeale D.R., Marshall F.F., Mostwin J.L., and Brendler C.B. Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup. J Urol 155 (1996) 490
11. Roehrborn C.G., Sagalowsky A.I., and Peters P.C. Long-term patient survival after cystectomy for regional metastatic transitional cell carcinoma of the bladder. J Urol 146 (1991) 36
12. Montie J.E. Against bladder sparing: surgery. J Urol 162 (1999) 452
13. Kachnic L.A., Kaufman D.S., Heney N.M., Althausen A.F., Griffin P.P., Zietman A.L., et al. Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 15 (1997) 1022
14. Shipley W.U., Kaufman D.S., Heney N.M., Althausen A.F., and Zietman A.L. An update of selective bladder preservation by combined modality therapy for invasive bladder cancer. Eur Urol 33 suppl (1998) 32
15. Sauer R., Birkenhake S., Kuhn R., Wittekind C., Schrott K.M., and Martus P. Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys 40 (1998) 121
16. Housset M., Maulard C., Chretien Y., Dufour B., Delanian S., Huart J., et al. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 11 (1993) 2150
17. Dunst J., Sauer R., Schrott K.M., Kuhn R., Wittekind C., and Altendorf-Hofmann A. Organ-sparing treatment of advanced bladder cancer: a 10-year experience. Int J Radiat Oncol Biol Phys 30 (1994) 261
18. Herr H.W. Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 61 (2003) 105
19. Herr H.W., Faulkner J.R., Grossman H.B., Natale R.B., DeVere White R., Sarosdy M.F., et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 22 (2004) 2781